5F-PB-22: Difference between revisions
>Oskykins m Text replacement - " Synthetic cannabinoid " to " Synthetic cannabinoid " |
>Oskykins m Text replacement - " synthetic cannabinoid " to " synthetic cannabinoid " |
||
Line 25: | Line 25: | ||
*'''[[Effect::Dehydration]]'''- This is known colloquially as "cotton mouth" in popular American and United Kingdom culture. | *'''[[Effect::Dehydration]]'''- This is known colloquially as "cotton mouth" in popular American and United Kingdom culture. | ||
*'''[[Effect::Vasodilation]]''' - Cannabinoids appear to decrease blood pressure by dilating the blood vessels and increasing blood flow throughout the body. The arteries in the eyeball expand from the decreased blood pressure and the heart rate increases to compensate for the reduction in pressure. | *'''[[Effect::Vasodilation]]''' - Cannabinoids appear to decrease blood pressure by dilating the blood vessels and increasing blood flow throughout the body. The arteries in the eyeball expand from the decreased blood pressure and the heart rate increases to compensate for the reduction in pressure. | ||
*'''[[Effect::Pain relief]]''' - Cannabinoids have been clinically demonstrated to provide pain relief via agonism of cannabinoid receptors CB<sub>1</sub> and CB<sub>2</sub>, which extends to synthetic cannabinoid receptor agonists. <ref>http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4637.2009.00703.x/abstract</ref><ref>Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials | http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2011.03970.x/abstract</ref> | *'''[[Effect::Pain relief]]''' - Cannabinoids have been clinically demonstrated to provide pain relief via agonism of cannabinoid receptors CB<sub>1</sub> and CB<sub>2</sub>, which extends to [[synthetic cannabinoid]] receptor agonists. <ref>http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4637.2009.00703.x/abstract</ref><ref>Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials | http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2011.03970.x/abstract</ref> | ||
*'''[[Effect::Perception of increased weight]]''' ''or'' '''[[Perception of decreased weight|Perception of decreased weight]]''' | *'''[[Effect::Perception of increased weight]]''' ''or'' '''[[Perception of decreased weight|Perception of decreased weight]]''' | ||
*'''[[Effect::Changes in gravity]]''' - 5F-PB-22, like other cannabinoids, is capable of causing vertigo with which the environment appears to be spinning or oscillating. At moderate doses, it can spontaneously induce the sensation of falling, which can be overwhelming and uncomfortable. The propensity of this is greatly reduced and eliminated in proportion to tolerance. | *'''[[Effect::Changes in gravity]]''' - 5F-PB-22, like other cannabinoids, is capable of causing vertigo with which the environment appears to be spinning or oscillating. At moderate doses, it can spontaneously induce the sensation of falling, which can be overwhelming and uncomfortable. The propensity of this is greatly reduced and eliminated in proportion to tolerance. |